These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10667412)

  • 1. How should atypical prostate needle biopsies be reported? Controversies regarding the term "ASAP".
    Epstein JI
    Hum Pathol; 1999 Dec; 30(12):1401-2. PubMed ID: 10667412
    [No Abstract]   [Full Text] [Related]  

  • 2. ASAP. Atypical small acinar proliferations.
    Wightman HR
    Hum Pathol; 1999 Dec; 30(12):1403; author reply 1404. PubMed ID: 10667414
    [No Abstract]   [Full Text] [Related]  

  • 3. ASAP. Atypical small acinar proliferations.
    Rosen S; Upton M
    Hum Pathol; 1999 Dec; 30(12):1403; author reply 1404. PubMed ID: 10667413
    [No Abstract]   [Full Text] [Related]  

  • 4. ASAP is a valid diagnosis. Atypical small acinar proliferation.
    Iczkowski KA; Cheng L; Qian J; Shanks J; Gadaleanu V; Bostwick DG; Ramnani DM
    Hum Pathol; 1999 Dec; 30(12):1403-4. PubMed ID: 10667415
    [No Abstract]   [Full Text] [Related]  

  • 5. Immediate radical prostatectomy in patients with atypical small acinar proliferation. Over treatment?
    Brausi M; Castagnetti G; Dotti A; De Luca G; Olmi R; Cesinaro AM
    J Urol; 2004 Sep; 172(3):906-8; discussion 908-9. PubMed ID: 15310995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical small acinar proliferation (ASAP) on extended prostatic biopsies: predictive factors of cancer detection on repeat biopsies.
    Scattoni V; Roscigno M; Freschi M; Dehò F; Raber M; Briganti A; Fantini G; Nava L; Montorsi F; Rigatti P
    Arch Ital Urol Androl; 2005 Mar; 77(1):31-6. PubMed ID: 15906787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical small acinar proliferation (ASAP): Is a repeat biopsy necessary ASAP? A multi-institutional review.
    Leone A; Gershman B; Rotker K; Butler C; Fantasia J; Miller A; Afiadata A; Amin A; Zhou A; Jiang Z; Sebo T; Mega A; Schiff S; Pareek G; Golijanin D; Yates J; Karnes RJ; Renzulli J
    Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):68-71. PubMed ID: 26857145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of "suspicious for malignancy" in prostate biopsies: predictive value for cancer.
    Iczkowski KA; Bassler TJ; Schwob VS; Bassler IC; Kunnel BS; Orozco RE; Bostwick DG
    Urology; 1998 May; 51(5):749-57; discussion 757-8. PubMed ID: 9610588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate cancer diagnosed after initial biopsy with atypical small acinar proliferation suspicious for malignancy is similar to cancer found on initial biopsy.
    Iczkowski KA; Chen HM; Yang XJ; Beach RA
    Urology; 2002 Nov; 60(5):851-4. PubMed ID: 12429314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical small acinar proliferation at index prostate biopsy: rethinking the re-biopsy paradigm.
    Ynalvez LA; Kosarek CD; Kerr PS; Mahmoud AM; Eyzaguirre EJ; Orihuela E; Sonstein JN; Williams SB
    Int Urol Nephrol; 2018 Jan; 50(1):1-6. PubMed ID: 29064003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate cancer detection rate and the importance of premalignant lesion in rebiopsy.
    Aganovic D; Prcic A; Kulovac B; Hadziosmanovic O
    Med Arh; 2011; 65(2):109-12. PubMed ID: 21585187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate adenocarcinoma detected after high-grade prostatic intraepithelial neoplasia or atypical small acinar proliferation.
    López JI
    BJU Int; 2007 Dec; 100(6):1272-6. PubMed ID: 17850386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limiting the diagnosis of atypical small glandular proliferations in needle biopsies of the prostate by the use of immunohistochemistry.
    Helpap B; Köllermann J; Oehler U
    J Pathol; 2001 Mar; 193(3):350-3. PubMed ID: 11241415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate atypia: does repeat biopsy detect clinically significant prostate cancer?
    Dorin RP; Wiener S; Harris CD; Wagner JR
    Prostate; 2015 May; 75(7):673-8. PubMed ID: 25597982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The optimal rebiopsy prostatic scheme depends on patient clinical characteristics: results of a recursive partitioning analysis based on a 24-core systematic scheme.
    Scattoni V; Raber M; Capitanio U; Abdollah F; Roscigno M; Angiolilli D; Maccagnano C; Gallina A; Saccà A; Freschi M; Doglioni C; Rigatti P; Montorsi F
    Eur Urol; 2011 Oct; 60(4):834-41. PubMed ID: 21820797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of prostate needle biopsies in a population-based screening study: the impact of borderline lesions.
    Hoedemaeker RF; Kranse R; Rietbergen JB; Kruger AE; Schröder FH; van der Kwast TH
    Cancer; 1999 Jan; 85(1):145-52. PubMed ID: 9921986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical hyperplasia of the prostate. A pitfall in the cytologic diagnosis of carcinoma.
    de Gaetani CF; Trentini GP
    Acta Cytol; 1978; 22(6):483-6. PubMed ID: 83770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeat prostate biopsy and the incremental risk of clinically insignificant prostate cancer.
    Resnick MJ; Lee DJ; Magerfleisch L; Vanarsdalen KN; Tomaszewski JE; Wein AJ; Malkowicz SB; Guzzo TJ
    Urology; 2011 Mar; 77(3):548-52. PubMed ID: 21215436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical prostatic glandular proliferations on needle biopsy: Diagnostic implications, use of immunohistochemistry, and clinical significance.
    Samaratunga H; Gardiner RA; Yaxley J; Brown I
    Anal Quant Cytol Histol; 2006 Apr; 28(2):104-10. PubMed ID: 16637513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adequate tissue sampling of prostate core needle biopsies.
    Shaw EB; Carter JB; Daniel BW; Wofford ED
    Am J Clin Pathol; 1997 Sep; 108(3):359-60. PubMed ID: 9291462
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.